This is One North Stories, an A*START CENTRAL PodcastIn our previous episode with Matwerkz, we heard how passion and mission-driven impact drives global recognition. This week, we continue with Lucence, an A*STAR spinoff pioneering liquid biopsy technology for earlier, less invasive cancer detection.Led by Dr. Tan Min Han, Lucence has since raised over US$70M, secured the first-ever US Medicare coverage for an Asian cancer test, and built a global hub-and-spoke model with labs in Singapore and Silicon Valley.Dr. Tan shares what it takes to expand across borders, scale in diverse healthcare systems, and relentlessly bridge the gap between science and real-world adoption. His advice to founders is clear: move quickly, communicate relentlessly, and surround yourself with teams that share the mission — because the need for impactful solutions is immediate and immense.Please check out the socials of our guest:Dr. Tan Min Han (LinkedIn)Lucence (Website)Thank you for listening. If you like what you’ve heard, please share with a friend. After that, please subscribe and review us wherever you get your podcasts.Check out A*START CENTRAL (Website, LinkedIn)If you have future episode ideas, segments ideas or want to partner with us on this exciting journey, please get in touch: [email protected]

Ver todos los episodios